Biotech · Public company · Durham, NC, US
Biocryst Pharmaceuticals Inc
Ticker BCRX · SEC CIK 0000882796
Track this companyFree. Adds Biocryst Pharmaceuticals Inc to your Dealase workspace and tells you when its record changes.
Clinical trials101 recruiting or active
Pipeline programs8From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availableNo recent cash burn filed
Pipeline8
- BCX4161Phase 3 · Hereditary AngioedemaClinicalTrials.gov · fetched Nov 12, 2026
- BCX7353Phase 3 · Hereditary AngioedemaClinicalTrials.gov · fetched Nov 12, 2026
- BCX7353 capsulesPhase 3 · Hereditary AngioedemaClinicalTrials.gov · fetched Nov 12, 2026
- OseltamivirPhase 3 · InfluenzaClinicalTrials.gov · fetched Nov 12, 2026
- PeramivirPhase 3 · InfluenzaClinicalTrials.gov · fetched Nov 12, 2026
- avoralstatPhase 1 · Diabetic Macular Edema (DME)ClinicalTrials.gov · fetched Nov 12, 2026
- BCX17725Phase 1 · Netherton SyndromeClinicalTrials.gov · fetched Nov 12, 2026
- galidesivirPhase 1 · Marburg Virus DiseaseClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials10
- A Study of Avoralstat In Participants With Diabetic Macular EdemaPHASE1 · TERMINATED · started Oct 2, 2025ClinicalTrials.gov NCT07228559 · fetched Nov 12, 2026
- A Study of the Safety, Tolerability, Pharmacokinetics, and Immunogenicity of BCX17725PHASE1 · ACTIVE_NOT_RECRUITING · started Sep 26, 2024ClinicalTrials.gov NCT06539507 · fetched Nov 12, 2026
- A Study to Evaluate the Single Dose Safety, Tolerability and Pharmacokinetics of IV BCX4430PHASE1 · COMPLETED · started Dec 10, 2018ClinicalTrials.gov NCT03800173 · fetched Nov 12, 2026
- A Long Term Safety Study of BCX7353 in Hereditary AngioedemaPHASE2_PHASE3 · COMPLETED · started Feb 16, 2018ClinicalTrials.gov NCT03472040 · fetched Nov 12, 2026
- Efficacy and Safety Study of BCX7353 as an Oral Treatment for the Prevention of Attacks in HAEPHASE3 · COMPLETED · started Feb 6, 2018ClinicalTrials.gov NCT03485911 · fetched Nov 12, 2026
- Safety, PK and Effectiveness of IV Peramivir in Elderly and Higher Risk Subjects With Uncomplicated InfluenzaPHASE3 · COMPLETED · started Dec 1, 2015ClinicalTrials.gov NCT02635724 · fetched Nov 12, 2026
- Safety, PK and Effectiveness of IV Peramivir Versus Oseltamivir in Pediatric Subjects With Uncomplicated InfluenzaPHASE3 · COMPLETED · started Mar 11, 2015ClinicalTrials.gov NCT02369159 · fetched Nov 12, 2026
- 12-Week Safety and Efficacy Study of BCX4161 as an Oral Prophylaxis Against HAE AttacksPHASE2_PHASE3 · COMPLETED · started Dec 17, 2014ClinicalTrials.gov NCT02303626 · fetched Nov 12, 2026
- A Study to Evaluate the Efficacy and Safety of Intravenous Peramivir in Subjects With Uncomplicated Influenza.PHASE3 · WITHDRAWN · started Oct 1, 2010ClinicalTrials.gov NCT01224795 · fetched Nov 12, 2026
- Intramuscular Peramivir in Subjects With Uncomplicated Acute InfluenzaPHASE3 · TERMINATED · started Jan 1, 2008ClinicalTrials.gov NCT00610935 · fetched Nov 12, 2026
SEC filings12
- 10-Q · 10-QSEC EDGAR · filed Nov 4, 2026 · fetched Nov 12, 2026
- 8-K · FORM 8-KSEC EDGAR · filed Nov 4, 2026 · fetched Nov 12, 2026
- 10-Q · 10-QSEC EDGAR · filed Aug 5, 2026 · fetched Nov 12, 2026
- 8-K · FORM 8-KSEC EDGAR · filed Aug 5, 2026 · fetched Nov 12, 2026
- 8-K/A · FORM 8-K/ASEC EDGAR · filed Aug 4, 2026 · fetched Nov 12, 2026
- 8-K · FORM 8-KSEC EDGAR · filed Jun 29, 2026 · fetched Nov 12, 2026
- 8-K · FORM 8-KSEC EDGAR · filed Jun 12, 2026 · fetched Nov 12, 2026
- 10-Q · 10-QSEC EDGAR · filed May 6, 2026 · fetched Nov 12, 2026
- 8-K · FORM 8-KSEC EDGAR · filed May 6, 2026 · fetched Nov 12, 2026
- 8-K · FORM 8-KSEC EDGAR · filed May 4, 2026 · fetched Nov 12, 2026
- 10-K · 10-KSEC EDGAR · filed Feb 26, 2026 · fetched Nov 12, 2026
- 8-K · FORM 8-KSEC EDGAR · filed Feb 26, 2026 · fetched Nov 12, 2026